Vitamin D3 for GLP-1-Associated Bone Density Loss

Vitamin D3 (cholecalciferol) is a fat-soluble vitamin and a precursor to the steroid hormone calcitriol (1,25-dihydroxyvitamin D). Cholecalciferol is hydroxylated in the liver to 25(OH)D (the form measured on standard labs), then again in the kidney to the active hormone calcitriol. Calcitriol's primary action is to up-regulate intestinal calcium absorption — the bottleneck for bone mineralization. In the GLP-1 bone-preservation context, three mechanisms matter. First, adequate calcium absorption requires adequate 25(OH)D status; supplementing D3 in someone with suboptimal 25(OH)D (below ~30 ng/mL by most laboratory thresholds) is the upstream lever for getting more dietary calcium into the bone-mineralization pool. Second, vitamin D and calcium together have meta-analytic evidence of fracture-risk reduction in postmenopausal populations, the demographic most overlapping with GLP-1 users. Third, vitamin D receptors are expressed in osteoblasts and osteoclasts, and adequate vitamin D status is associated with healthier bone remodeling balance — though the trial evidence for vitamin D monotherapy on BMD is more modest than the combination evidence. The D3+K2 conversation deserves precision. Vitamin K2 (MK-7) activates osteocalcin, a protein that helps direct calcium into bone matrix rather than soft tissue. The mechanism is clean. The clinical evidence base for K2 specifically on fracture outcomes is more limited than the D3+calcium evidence, but the rationale is reasonable, especially in a cohort already supplementing D3 at the higher end of the range. This is distinct from the established-osteoporosis treatment conversation. For T-scores ≤ -2.5, the standard of care includes bisphosphonates, denosumab, or anabolic agents — vitamin D3 is a foundational layer, not the active intervention. For the GLP-1 preservation context, vitamin D3 sits much closer to the primary intervention because the goal is preserving rather than rebuilding BMD.

The most important shopping decision for the GLP-1 bone-density context is not which D3 brand you buy — it is whether you have a recent 25(OH)D level and whether the rest of the preservation protocol (calcium intake, resistance training, adequate protein) is in place. Vitamin D3 is the upstream micronutrient lever, but it does not work in isolation. Get a baseline 25(OH)D level if you have not had one in the past year. Most labs report a 'sufficient' threshold of 30 ng/mL; the literature on bone outcomes generally supports targeting 30–50 ng/mL. Below 20 ng/mL is deficient and warrants more aggressive repletion (often 50,000 IU weekly under clinical supervision). Between 20 and 30 ng/mL is the insufficient range where 4000–5000 IU/day for 8–12 weeks then reassessment is a reasonable empirical approach. Above 30 ng/mL, 1000–2000 IU/day maintenance is typical. The D3+K2 question deserves precision. K2 MK-7 has a mechanistic case for directing calcium into bone, and the D3+K2 pairing makes the supplement story cleaner. But K2's clinical evidence base for fracture outcomes is more limited than D3+calcium. If you eat leafy greens, hard cheeses, and fermented foods regularly, your dietary K2 may already be adequate. If your diet runs low on these, the Pure Encapsulations D3+K2 pairing is a reasonable single-capsule choice. If you take warfarin or another vitamin K-sensitive anticoagulant, do not add K2 without your prescribing clinician's input. Think about the stack, not the single bottle. For GLP-1 bone preservation specifically, the highest-leverage interventions are: hit calcium intake at 1000–1200 mg/day (food first — dairy, leafy greens, fortified plant milks); do at least two resistance-training sessions per week (mechanical loading is the strongest signal for bone retention); hit total protein at 1.6–2.2 g/kg body weight (the muscle-bone axis is real); ensure 25(OH)D is in the 30–50 ng/mL range; and have the GLP-1 dose-rate conversation with your prescribing clinician if weight loss is exceeding 1% body weight per week sustained. Food-first note: vitamin D3 supplementation does not replace dietary calcium, resistance training, or adequate protein — the three actual drivers of bone preservation during weight loss. Vitamin D3 is the micronutrient cofactor that lets the rest of the protocol work.